Your browser doesn't support javascript.
Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease
Medicine in Microecology ; 6 (no pagination), 2020.
Article in English | EMBASE | ID: covidwho-2257268
ABSTRACT
Fecal microbiota transplantation (FMT), as an emerging therapy, can be used to treat microbiota related diseases. Progresses in donor screening, washed microbiota preparation, microbiota delivery routes, clinical administrative strategies, and long-term safety are moving FMT forward. Increasing clinical studies, especially those randomized controlled trials about ulcerative colitis and pilot real-word studies about serious inflammatory bowel disease (IBD), have been conducted. This review presents the latest findings about the efficacy, safety and methodology of FMT in treating IBD.Copyright © 2020 The Authors
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Medicine in Microecology Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Medicine in Microecology Year: 2020 Document Type: Article